Cas no 26153-88-8 (1-Pentanamine, N,N-dimethyl-)
1-Pentanamine, N,N-dimethyl- Chemical and Physical Properties
Names and Identifiers
-
- 1-Pentanamine, N,N-dimethyl-
- N,N-dimethyl pentylamine
- Dimethyl-pentyl-amine
- N,N-Dimethyl-1-pentanamine
- EN300-7085023
- IDFANOPDMXWIOP-UHFFFAOYSA-N
- BDBM50047898
- 26153-88-8
- CHEMBL47794
- N,N-Dimethyl-1-pentanamine #
- N,N-dimethyl-pentanamine
- SCHEMBL71563
- dimethyl(pentyl)amine
-
- Inchi: 1S/C7H17N/c1-4-5-6-7-8(2)3/h4-7H2,1-3H3
- InChI Key: IDFANOPDMXWIOP-UHFFFAOYSA-N
- SMILES: N(C)(C)CCCCC
Computed Properties
- Exact Mass: 115.13621
- Monoisotopic Mass: 115.136
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 8
- Rotatable Bond Count: 4
- Complexity: 41.7
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.1
- Topological Polar Surface Area: 3.2?2
Experimental Properties
- PSA: 3.24
1-Pentanamine, N,N-dimethyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Enamine | EN300-7085023-0.05g |
dimethyl(pentyl)amine |
26153-88-8 | 0.05g |
$443.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-0.1g |
dimethyl(pentyl)amine |
26153-88-8 | 0.1g |
$464.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-0.25g |
dimethyl(pentyl)amine |
26153-88-8 | 0.25g |
$485.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-0.5g |
dimethyl(pentyl)amine |
26153-88-8 | 0.5g |
$507.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-1.0g |
dimethyl(pentyl)amine |
26153-88-8 | 1g |
$528.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-2.5g |
dimethyl(pentyl)amine |
26153-88-8 | 2.5g |
$1034.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-5.0g |
dimethyl(pentyl)amine |
26153-88-8 | 5g |
$1530.0 | 2023-05-30 | ||
| Enamine | EN300-7085023-10.0g |
dimethyl(pentyl)amine |
26153-88-8 | 10g |
$2269.0 | 2023-05-30 |
1-Pentanamine, N,N-dimethyl- Related Literature
-
Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
-
Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Guiying Zhang,Maosheng Cheng,Yanni Li,Keliang Liu,Lifeng Cai Chem. Commun., 2013,49, 11086-11088
Additional information on 1-Pentanamine, N,N-dimethyl-
Research Brief on 1-Pentanamine, N,N-dimethyl- (CAS: 26153-88-8): Recent Advances and Applications
1-Pentanamine, N,N-dimethyl- (CAS: 26153-88-8) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. This tertiary amine has garnered attention due to its potential applications in drug development, particularly as a building block for more complex molecules. Recent studies have explored its physicochemical properties, synthetic pathways, and biological activities, shedding light on its versatility in medicinal chemistry.
A 2023 study published in the *Journal of Medicinal Chemistry* investigated the role of 1-Pentanamine, N,N-dimethyl- as a precursor in the synthesis of novel antipsychotic agents. The research highlighted its ability to enhance blood-brain barrier penetration, making it a valuable scaffold for central nervous system (CNS) drug development. The study utilized molecular docking simulations and in vitro assays to demonstrate its binding affinity to dopamine receptors, suggesting potential therapeutic applications for neurological disorders.
In addition to its pharmacological potential, recent advancements in synthetic chemistry have optimized the production of 1-Pentanamine, N,N-dimethyl-. A 2024 paper in *Organic Process Research & Development* described a green chemistry approach using catalytic hydrogenation, which improved yield and reduced environmental impact. This method aligns with the growing emphasis on sustainable practices in pharmaceutical manufacturing.
Further research has explored the compound's role in prodrug design. A 2023 study in *Bioorganic & Medicinal Chemistry Letters* demonstrated how 1-Pentanamine, N,N-dimethyl- could be used to improve the solubility and bioavailability of poorly water-soluble drugs. By conjugating the amine group with hydrophobic drug molecules, researchers achieved enhanced drug delivery profiles, paving the way for more effective oral formulations.
Despite these promising developments, challenges remain in the widespread adoption of 1-Pentanamine, N,N-dimethyl-. Regulatory considerations, such as its classification under the REACH framework, require careful evaluation. Additionally, further in vivo studies are needed to fully elucidate its pharmacokinetic and toxicological profiles. Nonetheless, the compound's versatility and potential for innovation in drug design make it a focal point for ongoing research in the chemical biology and pharmaceutical sectors.
26153-88-8 (1-Pentanamine, N,N-dimethyl-) Related Products
- 1116-76-3(Trioctylamine)
- 1120-24-7(N,N-dimethyldecylamine)
- 4088-22-6(N-Methyldioctadecylamine)
- 112-75-4(N,N-Dimethyltetradecylamine)
- 124-28-7(N,N-Dimethyloctadecan-1-amine)
- 927-62-8(N,N-Dimethylbutylamine)
- 10108-86-8(N,N,N-Trimethyloctan-1-aminium chloride)
- 505-86-2(Hexadecyltrimethylammonium Hydroxide (10% in Water))
- 112-69-6(N,N-Dimethylhexadecylamine)
- 2915-90-4(Didodecylmethylamine)